EURAZEO COMPLETES THE SALE OF DORC TO CARL ZEISS MEDITEC AG
Paris, April 3, 2024


Eurazeo has completed the disposal of DORC (“Dutch Ophthalmic Research Center”) to Carl Zeiss
Meditec AG, one of the world’s leading medical technology companies.

Established in 1983, and headquartered in the Netherlands, DORC is a world -leading and high
growth ophthalmic surgery platform in the Vitreoretinal (“VR”) and Cataract market. Over the last
four years, Eurazeo has supported DORC’s strong growth by bolstering its sector expertise and
scale, accelerating DORC’s international expansion, particularly in the United States and Asia ,
through continued innovation with multiple new products launches and through M&A with two
successful strategic acquisitions in Germany and the US .

Eurazeo‘s investment in DORC is a good example of the Mid-large buyout playbook, which consists
of selecting and supporting leading mid-market companies with solid fundamentals and a
differentiated positioning in sectors with strong tailwinds such as Healthcare.

The transaction has generated a gross cash-on-cash of 2.6x on Eurazeo’s initial investment and a
gross internal rate of return (IRR) of 24% with around €386 million of proceeds being allocated to
Eurazeo balance sheet.




ABOUT EURAZEO
• Eurazeo is a leading European investment group, with a diversified portfolio of €35.0 billion in
assets under management, including €24 billion from third parties, invested in almost 600
companies. With its considerable private equity, private debt, real estate and infrastructure
expertise, the Group invests in companies of all sizes, supporting their development through
the commitment of its more than 400 professionals and offering deep sector exper tise, a
gateway to global markets, and a responsible and stable foothold for transformational growth.
Its solid institutional and family shareholder base, robust financial structure free of structural
debt and flexible investment horizon enable Eurazeo to support its companies over the long
term.
• Eurazeo has offices in Paris, New York, London, Frankfurt, Berlin, Milan, Madrid, Luxembourg,
Shanghai, Seoul, Singapore and São Paulo.
• Eurazeo is listed on Euronext Paris.
• ISIN: FR0000121121 - Bloomberg: RF FP - Reuters: EURA.PA




EURAZEO
1 rue Georges Berger – 75017 Paris
www.eurazeo.com
EURAZEO CONTACT PRESS CONTACT


Coralie Savin David Sturken
GROUP CHIEF COMMUNICATIONS OFFICER H-ADVISORS MAITLAND
csavin@eurazeo.com David.sturken@h-advisors.global
+33 (0)6 86 89 57 48 +44 (0) 7990 595 913


Pierre Bernardin
HEAD OF INVESTOR RELATIONS
pbernardin@eurazeo.com
+33 (0)1 44 15 16 76




2/2